Cashu
Request for Information on Cyclacel Pharmaceuticals for Summary Creation
1 day ago
Stocks
Health Care
cycc
Cyclacel Pharmaceuticals
CYCC
-0.76 (-4.46%)
16.385
USD
At close at Jul 25, 17:37 UTC
Overview
Loading chart...
Key Stats
Market Cap
449.28K
Dividend Yield
0.00%
P/E Ratio
-0.05
EPS
-3.22
Revenue
43.00K
Avg. Volume
25.82M
About
What does CYCC do?
Cyclacel Pharmaceuticals, based in Berkeley Heights, New Jersey, develops cancer medicines focusing on cell cycle and transcriptional regulation. Its key programs include fadraciclib and plogosertib, targeting solid tumors and hematological malignancies.
Join our newsletter to keep up to date with us!
